Munagala Karthik, Vijay Praveen S, Maadam Keerthana, Chopra Shamit, Kishve Sanjay
Department of ENT, ESIC Medical College Hospital, Hyderabad, Telangana India.
Sunshine Hospital, Hyderabad, Telangana India.
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2217-2221. doi: 10.1007/s12070-020-02069-4. Epub 2020 Aug 31.
Dynamic risk stratification (DRS) in DTC has been considered necessary to deliver correct follow-up (FU) treatment, avoiding overtreatment of low risk/intermediate risk patients as well as inadequate treatment of high risk patients. However, it's clinical applicability has been questioned in comparison with more conventional FU protocols. We aimed to know the predictive reliability of DRS in monitoring FU of DTC in a resource-constrained setting across various risk groups, especially when compared with clinical examination alone.
分化型甲状腺癌（DTC）的动态风险分层（DRS）被认为对于提供正确的随访（FU）治疗是必要的，可避免对低风险/中风险患者过度治疗以及对高风险患者治疗不足。然而，与更传统的随访方案相比，其临床适用性受到了质疑。我们旨在了解在资源有限的环境中，DRS在监测不同风险组DTC随访中的预测可靠性，特别是与单独的临床检查相比时。
